Stock FRE FRESENIUS SE & CO. KGAA
Add to a list
To use this feature you must be a member
Log inSign up

Financials Fresenius SE & Co. KGaA

Equities

FRE

DE0005785604

Healthcare Facilities & Services

Real-time Estimate Tradegate
Other stock markets
 11:05:53 2024-06-12 am EDT 		5-day change 1st Jan Change
30.08 EUR +2.23% Intraday chart for Fresenius SE & Co. KGaA +1.35% +7.02%
Jun. 11 FRESENIUS SE : Buy rating from Deutsche Bank ZD
Jun. 06 Barclays Lifts Fresenius PT, Maintains Overweight Rating MT

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 27,969 21,095 19,769 14,785 15,810 16,576 - -
Enterprise Value (EV) 1 53,573 45,171 44,160 39,799 29,078 28,978 28,266 27,615
P/E ratio 14.8 x 12.4 x 10.9 x 10.8 x -26.7 x 12.2 x 9.44 x 8.46 x
Yield 1.67% 2.33% 2.6% 3.5% - 3.14% 3.54% 3.81%
Capitalization / Revenue 0.79 x 0.58 x 0.53 x 0.36 x 0.71 x 0.75 x 0.71 x 0.68 x
EV / Revenue 1.51 x 1.25 x 1.18 x 0.97 x 1.3 x 1.31 x 1.22 x 1.13 x
EV / EBITDA 7.54 x 6.33 x 6.47 x 6.32 x 8.5 x 7.84 x 7.05 x 6.48 x
EV / FCF 49.6 x 18.2 x 37 x 17.4 x 8.75 x 19.4 x 19.6 x 17.7 x
FCF Yield 2.02% 5.49% 2.7% 5.73% 11.4% 5.16% 5.1% 5.66%
Price to Book 1.67 x 1.24 x 1.04 x 0.72 x 0.83 x 0.83 x 0.79 x 0.82 x
Nbr of stocks (in thousands) 557,380 557,472 558,454 563,237 563,237 563,237 - -
Reference price 2 50.18 37.84 35.40 26.25 28.07 29.43 29.43 29.43
Announcement Date 2/20/20 2/23/21 2/22/22 3/4/23 2/21/24 - - -
1EUR in Million2EUR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 35,409 36,277 37,520 40,840 22,299 22,163 23,207 24,372
EBITDA 1 7,104 7,132 6,825 6,294 3,422 3,697 4,010 4,260
EBIT 1 4,599 4,612 4,252 4,004 2,262 2,389 2,628 2,831
Operating Margin 12.99% 12.71% 11.33% 9.8% 10.14% 10.78% 11.33% 11.62%
Earnings before Tax (EBT) 1 3,912 3,726 3,652 2,814 715 1,968 2,227 2,451
Net income 1 1,883 1,707 1,818 1,372 -594 1,357 1,724 1,914
Net margin 5.32% 4.71% 4.85% 3.36% -2.66% 6.12% 7.43% 7.85%
EPS 2 3.380 3.060 3.260 2.440 -1.050 2.412 3.118 3.477
Free Cash Flow 1 1,081 2,478 1,193 2,281 3,322 1,496 1,440 1,563
FCF margin 3.05% 6.83% 3.18% 5.59% 14.9% 6.75% 6.21% 6.41%
FCF Conversion (EBITDA) 15.22% 34.74% 17.48% 36.24% 97.08% 40.46% 35.92% 36.69%
FCF Conversion (Net income) 57.41% 145.17% 65.62% 166.25% - 110.22% 83.58% 81.68%
Dividend per Share 2 0.8400 0.8800 0.9200 0.9200 - 0.9238 1.042 1.121
Announcement Date 2/20/20 2/23/21 2/22/22 3/4/23 2/21/24 - - -
1EUR in Million2EUR
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2020 S1 2021 S1 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales 1 18,055 18,230 9,966 9,720 10,018 10,459 10,643 10,225 10,359 5,518 5,678 5,704 5,725 5,630 5,650 - -
EBITDA 1 - - 1,868 1,658 - 1,658 - 1,585 1,649 - - 924 919.6 867.1 1,009 - -
EBIT 1 2,248 2,039 1,166 996 1,003 949 1,052 908 956 519 634 633 635.9 594.9 667 - -
Operating Margin 12.45% 11.18% 11.7% 10.25% 10.01% 9.07% 9.88% 8.88% 9.23% 9.41% 11.17% 11.1% 11.11% 10.57% 11.8% - -
Earnings before Tax (EBT) - - 1,001 784 729 551 - - - - - - - - - - -
Net income 1 - 906 499 413 383 321 255 346 80 -406 - 278 297.1 283.5 200.3 - -
Net margin - 4.97% 5.01% 4.25% 3.82% 3.07% 2.4% 3.38% 0.77% -7.36% - 4.87% 5.19% 5.04% 3.55% - -
EPS 2 1.560 1.620 0.9000 0.7400 0.6800 0.5700 0.4500 0.6100 0.1500 -0.7200 -1.090 0.4900 0.6526 0.5011 0.3541 - -
Dividend per Share 2 - - 0.9200 - - - 0.9200 - - - - - - - 0.9200 - -
Announcement Date 7/30/20 7/30/21 2/22/22 5/4/22 8/2/22 11/1/22 3/4/23 5/9/23 8/2/23 11/2/23 2/21/24 5/8/24 - - - - -
1EUR in Million2EUR
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 25,604 24,076 24,391 25,014 13,268 12,402 11,690 11,039
Net Cash position 1 - - - - - - - -
Leverage (Debt/EBITDA) 3.604 x 3.376 x 3.574 x 3.974 x 3.877 x 3.355 x 2.915 x 2.591 x
Free Cash Flow 1 1,081 2,478 1,193 2,281 3,322 1,496 1,440 1,563
ROE (net income / shareholders' equity) 11.3% 10.1% 10.1% 8.5% 7.9% 7.79% 8.39% 8.93%
ROA (Net income/ Total Assets) 3.19% 2.55% 2.62% 2.33% 2.47% 2.94% 3.49% 3.57%
Assets 1 58,973 66,826 69,305 58,871 -24,049 46,083 49,325 53,613
Book Value Per Share 2 30.10 30.40 34.00 36.20 33.70 35.40 37.40 36.00
Cash Flow per Share 2 6.310 11.70 9.100 7.480 3.780 4.050 5.100 5.160
Capex 1 2,433 2,366 2,017 1,917 1,134 1,158 1,246 1,288
Capex / Sales 6.87% 6.52% 5.38% 4.69% 5.09% 5.22% 5.37% 5.28%
Announcement Date 2/20/20 2/23/21 2/22/22 3/4/23 2/21/24 - - -
1EUR in Million2EUR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Fresenius SE & Co. KGaA

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
16
Last Close Price
29.43 EUR
Average target price
37.26 EUR
Spread / Average Target
+26.59%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Healthcare Facilities & Services

1st Jan change Capi.
FRESENIUS SE & CO. KGAA Stock Fresenius SE & Co. KGaA
+6.41% 17.78B
HCA HEALTHCARE, INC. Stock HCA Healthcare, Inc.
+24.25% 88.08B
CVS HEALTH CORPORATION Stock CVS Health Corporation
-24.01% 75.32B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY Stock Dr. Sulaiman Al Habib Medical Services Group Company
+5.70% 28.19B
LABCORP HOLDINGS INC. Stock Labcorp Holdings Inc.
-13.14% 16.64B
QUEST DIAGNOSTICS INCORPORATED Stock Quest Diagnostics Incorporated
+2.09% 15.64B
NATERA, INC. Stock Natera, Inc.
+79.55% 13.81B
TENET HEALTHCARE CORPORATION Stock Tenet Healthcare Corporation
+79.66% 13.26B
UNIVERSAL HEALTH SERVICES, INC. Stock Universal Health Services, Inc.
+21.81% 12.43B
DAVITA INC. Stock DaVita Inc.
+33.51% 12.27B
Other Healthcare Facilities & Services
  1. Stock Market
  2. Equities
  3. FRE Stock
  4. Financials Fresenius SE & Co. KGaA